| Literature DB >> 31795148 |
Karen Y Velasco-Alzate1, Anelize Bauermeister1,2, Marcelo M P Tangerina3, Tito M C Lotufo4, Marcelo J P Ferreira3, Paula C Jimenez5, Gabriel Padilla6, Norberto P Lopes2, Letícia V Costa-Lotufo1.
Abstract
Rocas Atoll is a unique environment in the equatorial Atlantic Ocean, hosting a large number of endemic species, however, studies on the chemical diversity emerging from this biota are rather scarce. Therefore, the present work aims to assess the metabolomic diversity and pharmacological potential of the microbiota from Rocas Atoll. A total of 76 bacteria were isolated and cultured in liquid culture media to obtain crude extracts. About one third (34%) of these extracts were recognized as cytotoxic against human colon adenocarcinoma HCT-116 cell line. 16S rRNA gene sequencing analyses revealed that the bacteria producing cytotoxic extracts were mainly from the Actinobacteria phylum, including Streptomyces, Salinispora, Nocardiopsis, and Brevibacterium genera, and in a smaller proportion from Firmicutes phylum (Bacillus). The search in the spectral library in GNPS (Global Natural Products Social Molecular Networking) unveiled a high chemodiversity being produced by these bacteria, including rifamycins, antimycins, desferrioxamines, ferrioxamines, surfactins, surugamides, staurosporines, and saliniketals, along with several unidentified compounds. Using an original approach, molecular networking successfully highlighted groups of compounds responsible for the cytotoxicity of crude extracts. Application of DEREPLICATOR+ (GNPS) allowed the annotation of macrolide novonestimycin derivatives as the cytotoxic compounds existing in the extracts produced by Streptomyces BRB-298 and BRB-302. Overall, these results highlighted the pharmacological potential of bacteria from this singular atoll.Entities:
Keywords: marine bacteria; metabolomics; microbial diversity; molecular network; secondary metabolites
Mesh:
Substances:
Year: 2019 PMID: 31795148 PMCID: PMC6949966 DOI: 10.3390/md17120671
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Cellular viability. Cytotoxicity of crude extracts produced by the recovered bacteria against HCT-116 carcinoma cell lines at 50 µg/mL (a) and 5 µg/mL (b), evaluated by the MTT assay after 72 h exposure. The extracts that presented cytotoxicity above 75% at 50 µg/mL were considered active. Among 76 extracts tested, (a) 26 were cytotoxic at 50 µg/mL, and (b) nine were also cytotoxic at 5 µg/mL.
Figure 2Phylogenetic relationships among recovered strains and most similar type species of bacteria obtained through Maximum Likelihood (RaxML) with 1000 bootstrap replications. Green lines indicate bootstrap support values > 70% for the branch. Terminals are colored according to the bacteria genera and follow the same pattern throughout this article. Accession numbers are shown on Table S1. The strains recovered from Rocas Atoll are coded by BRB followed by a three-digit number.
Figure 3Molecular network of extracts produced by bacteria recovered from Rocas Atoll, considering the positive ionization mode (ESI+) data after removal of solvent blank. Nodes represent parent masses, and their colors are according to the legend, where the noncytotoxic extracts (<75%) are in gray. Extracts that showed inhibition of cell growth above 75% are divided by taxonomic group in Actinobacteria (Streptomyces, Salinispora, Nocardiopsis, and Brevibacterium) and Firmicutes (Bacillus). Extracts considered cytotoxic produced by bacteria nonidentified are depicted in light green. Only clusters containing at least two nodes are shown.
Figure 4Heatmap showing the distribution of metabolites classes vs. bacterial phylogenetic tree. Only the bacteria that produced cytotoxic samples were considered. The chemical classes used here were obtained from the spectral library annotations. The ions/nodes referring to identified chemical classes were used to construct the heatmap using software R. The color represents the number of analogs (normalized by logarithmic scale) each strain produced for the respective chemical classes. The clustering was based on Ward’s method employing Euclidian distance.
Figure 5(a) Molecular structure of novonestmycin A; (b) UV spectrum referring to the novonestmycin derivative produced by the Streptomyces sp. BRB-302; (c) Cluster of an active molecular family produced exclusively by Streptomyces sp. BRB-298 and BRB-302 strains, in which the compound annotated by DEREPLICATOR+ is circled in red; (d) MS/MS spectrum of the ion m/z 1,229 annotated as novonestmycin derivative.